NDC properties for "Natesto 5.5 MG/ACTUAT Nasal Gel, 60 ACTUAT" (RxCUI 1596782)
About this data
The tables show NDC propoerties for Natesto 5.5 MG/ACTUAT Nasal Gel, 60 ACTUAT with the RxCUI 1596782
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Natesto 5.5 MG/ACTUAT Nasal Gel, 60 ACTUAT (RxCUI 1596782)
| MMSL_CODE | BD30210 |
|---|---|
| NDA | NDA205488 |
| RxCUI | 1596782 |
| SPL_SET_ID | 68d0447b-f75a-4fb2-96ba-de822b74aebb |
| SPL_SET_ID | dea6bed1-eaca-11e3-ac10-0800200c9a66 |
| Prescribable Synonym | Natesto 5.5 MG/ACTUAT Nasal Gel, 60 ACTUAT |
| RXNAV_STR | Natesto 5.5 MG/ACTUAT Nasal Gel, 60 ACTUAT |
| RxNorm Name | 60 ACTUAT testosterone 5.5 MG/ACTUAT Nasal Gel [Natesto] |
| RxNorm Synonym | Natesto 5.5 MG/ACTUAT Nasal Gel, 60 ACTUAT |
| Related queries | Interactions (for RxCUI 1596782) |
NDC Properties
NDC Item 42667551101
| NDC 9 | 42667-5511 |
|---|---|
| NDC 10 | 42667-5511-1 |
| NDC Item | 42667551101 |
| Packaging | 1 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR |
| COLORTEXT | white(white actuator, clear body) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 679163 |
| Labeler | Acerus Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-05-08 |
| Marketing status | ACTIVE |
| NDA | NDA205488 |
| Related queries | Properties for NDC 9 42667-5511 |
NDC Item 69654023901
| NDC 9 | 69654-239 |
|---|---|
| NDC 10 | 69654-239-01 |
| NDC Item | 69654023901 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (69654-239-01) / 60 GEL in 1 BOTTLE, PUMP |
| DCSA | CIII |
| FDA SPL set id | 436540 |
| Labeler | Aytu BioPharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-09-01 |
| Marketing status | ACTIVE |
| NDA | NDA205488 |
| Related queries | Properties for NDC 9 69654-239 |
NDC Item 42667551101
| NDC 9 | 42667-5511 |
|---|---|
| NDC 10 | 42667-5511-1 |
| NDC Item | 42667551101 |
| Packaging | 1 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR |
| COLORTEXT | white(white actuator, clear body) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 679163 |
| Labeler | Acerus Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-05-08 |
| Marketing status | ACTIVE |
| NDA | NDA205488 |
| Related queries | Properties for NDC 9 42667-5511 |
NDC Item 69654023901
| NDC 9 | 69654-239 |
|---|---|
| NDC 10 | 69654-239-01 |
| NDC Item | 69654023901 |
| Packaging | 1 BOTTLE, PUMP in 1 CARTON (69654-239-01) / 60 GEL in 1 BOTTLE, PUMP |
| DCSA | CIII |
| FDA SPL set id | 436540 |
| Labeler | Aytu BioPharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-09-01 |
| Marketing status | ACTIVE |
| NDA | NDA205488 |
| Related queries | Properties for NDC 9 69654-239 |